USNA
Usana Health Sciences, Inc.
NYSE · Consumer Defensive
| Jan 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Jan 2022 | Jan 2021 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jan 2016 | Jan 2015 | Dec 2013 | Dec 2012 | Dec 2011 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||||||||
| Capital Expenditures | 13.8M | 10.1M | 14.5M | 10.4M | 12.8M | 15.1M | 16.6M | 11.4M | 13.2M | 32.7M | 23.7M | 20.4M | 8.1M | 8.4M | 10.6M | 4.2M | 4.1M |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||||||||
| Free Cash Flow | 8.5M | 50.9M | 56.1M | 93.5M | 108.5M | 145.3M | 110.2M | 140.7M | 110.6M | 104.2M | 87.7M | 84.8M | 90.8M | 84.4M | 59.5M | 61.9M | 28.3M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |